1. Home
  2. STSS vs CNSP Comparison

STSS vs CNSP Comparison

Compare STSS & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STSS
  • CNSP
  • Stock Information
  • Founded
  • STSS 2017
  • CNSP 2017
  • Country
  • STSS United States
  • CNSP United States
  • Employees
  • STSS N/A
  • CNSP N/A
  • Industry
  • STSS Medical/Dental Instruments
  • CNSP Biotechnology: Pharmaceutical Preparations
  • Sector
  • STSS Health Care
  • CNSP Health Care
  • Exchange
  • STSS Nasdaq
  • CNSP Nasdaq
  • Market Cap
  • STSS 4.6M
  • CNSP 5.6M
  • IPO Year
  • STSS 2022
  • CNSP 2019
  • Fundamental
  • Price
  • STSS $5.87
  • CNSP $1.04
  • Analyst Decision
  • STSS
  • CNSP Hold
  • Analyst Count
  • STSS 0
  • CNSP 1
  • Target Price
  • STSS N/A
  • CNSP N/A
  • AVG Volume (30 Days)
  • STSS 2.6M
  • CNSP 4.9M
  • Earning Date
  • STSS 05-15-2025
  • CNSP 06-17-2025
  • Dividend Yield
  • STSS N/A
  • CNSP N/A
  • EPS Growth
  • STSS N/A
  • CNSP N/A
  • EPS
  • STSS N/A
  • CNSP N/A
  • Revenue
  • STSS N/A
  • CNSP N/A
  • Revenue This Year
  • STSS N/A
  • CNSP N/A
  • Revenue Next Year
  • STSS N/A
  • CNSP N/A
  • P/E Ratio
  • STSS N/A
  • CNSP N/A
  • Revenue Growth
  • STSS N/A
  • CNSP N/A
  • 52 Week Low
  • STSS $3.36
  • CNSP $0.77
  • 52 Week High
  • STSS $2,904.00
  • CNSP $414.00
  • Technical
  • Relative Strength Index (RSI)
  • STSS 42.25
  • CNSP 42.18
  • Support Level
  • STSS $3.44
  • CNSP $1.00
  • Resistance Level
  • STSS $7.04
  • CNSP $1.08
  • Average True Range (ATR)
  • STSS 0.51
  • CNSP 0.09
  • MACD
  • STSS 1.33
  • CNSP 0.00
  • Stochastic Oscillator
  • STSS 67.47
  • CNSP 19.05

About STSS Sharps Technology Inc.

Sharps Technology Inc is a medical device company. It offers syringes and other safety products. Sharps provensa, Securgard, and Sologard are ultra-low waste smart safety syringes designed to eliminate potentially infectious and accidental needlestick injuries.

About CNSP CNS Pharmaceuticals Inc.

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

Share on Social Networks: